Trodelvy (Sacituzumab govitecan-hziy)

Trodelvy is a Trop-2-directed antibody and topoisomerase inhibitor conjugate used to treat adult patients with:

• metastatic triple-negative breast cancer (mTNBC) who have received at least 2 prior therapies for metastatic disease.
• locally advanced/metastatic urothelial cancer (mUC) who have previously treated with a platinum-containing chemotherapy and either programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor. 

The recommended dose is 10 mg/kg weekly on Days 1 and 8 of each 21-day cycle, or until disease progression or unacceptable toxicity occurs. One should avoid substituting or combining Trodelvy with other irinotecan-containing medications. Administer only as an intravenous infusion, not as a bolus. Pre-infusion medicine and close monitoring are recommended, as well as necessary treatment changes to manage side effects.

• Sacituzumab Govitecan-hziy can cause severe or life-threatening neutropenia. Withhold it for absolute neutrophil count below 1500/mm3 on Day 1’st of any cycle or neutrophil count below 1000/mm3 on Day 8’th of any cycle. Withhold it for neutropenic fever. 
• Trodelvy breast cancer drug can cause severe diarrhea. Withhold it for Grade 3-4 diarrhea at the juncture of scheduled treatment administration and resume when resolved to ≤ Grade 1.
• Sacituzumab Govitecan-hziy can cause severe and life-threatening hypersensitivity. Pre-infusion drug for patients receiving sacituzumab govitecan hziy is recommended. Observe patients precisely for infusion-related reactions during each infusion and for at least 30 minutes following completion of each infusion. 
• Patients who are homozygous for the uridine diphosphate-glucuronosyl transferase 1A1 (UGT1A1)*28 allele are at greater risk for neutropenia and may be at greater risk for other adverse reactions following starting of trodelvy 180 mg treatment.
• Precisely assess patients with reduced UGT1A1 activity for the severe neutropenia. The apt dose for patients who are homozygous for UGT1A1*28 is not specified and should be considered based on the tolerance to treatment. 
• Mechanism of action suggest that the trodelvy therapy can be responsible for causing teratogenicity and/or embryo-fetal lethality in case administered to a pregnant woman.

What documents are required to import Trodelvy? 

Trodelvy (Sacituzumab govitecan-hziy) injection can be imported by patients or government hospitals on behalf of patients.

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patient’s diagnostic reports.
• Patient’s ID proof (issued by the Government of the respective country).

How is the order confirmed? 

The order will be confirmed only after the receipt of:

• A valid prescription from a doctor.
• Import permit if applicable.

Is Trodelvy available worldwide?

Trodelvy (Sacituzumab govitecan-hziy) injection is a prescription pharmaceutical drug that legally requires a medical prescription for dispensation.

Indian Pharma Network (IPN) facilitates the import of critical medications like Trodelvy globally, ensuring the named patient supply (NPS). IPN is the facilitator that provides essential support for:

• Availability of Trodelvy (Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka).
• Trodelvy available in India (Noida, Delhi, Mumbai, Gurgaon, Lucknow,  Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc
• Determining Medicine Price.
• Sourcing genuine and reliable sources from the USA, Canada, Europe, and Australia.
  
• Ensuring 100% transparency.

Trodelvy can be made available to patients, doctors, and hospitals in various countries across the globe. The order will be confirmed only after receiving a valid prescription from the doctor and, if required, an import permit.

Indian Pharma Network (IPN) can facilitate the supply of Trodelvy (prescription medicine) to locations worldwide while adhering to legal requirements (if applicable).

We assure quality and worldwide delivery as per the buyer’s specifications.

Indian Pharma Network is proficient in sourcing Trodelvy from around the world and has the capability to supply it. We offer global access to the best available treatment for our customers worldwide in countries like Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka.

Indian Pharma Network (IPN) is committed to dispensing any valid prescription promptly. All prescriptions are dispensed and verified by registered pharmacists and are dispatched only to the patient’s address. Your health and well-being are our top priorities

What is the Generic Name for the trade name drug Trodelvy®?

Sacituzumab govitecan-hziy is the Generic Name for the trade name drug Trodelvy®.

What is the Manufacturer’s Name of Trodelvy®?

Trodelvy® is manufactured by Gilead Sciences, Inc.

Is Trodelvy® approved by the FDA?

Yes. Trodelvy® is approved by the FDA. Date of first approval: April 22, 2020.

What strengths and dosage forms are available for Trodelvy®?

Trodelvy® is supplied as a 180 mg lyophilized powder in a single-dose vial, intended for intravenous infusion after reconstitution.

What are the most common side effects of Trodelvy® Injections?

The most commonly reported side effects of Trodelvy are diarrhea, nausea, fatigue, alopecia, constipation, vomiting, and decreased appetite.

What is the availability of Trodelvy® near Medanta Hospital in Gurgaon?

Patients receiving treatment near Medanta Hospital can obtain Trodelvy® through a patient-specific import pathway. With a valid oncologist’s prescription, the treatment can be arranged and delivered directly to the hospital in Gurgaon.

What is the availability of Trodelvy® in Bangalore?

Trodelvy® is not commercially marketed in Bangalore, but patients can still access it through regulated import provisions. Once prescribed, the medicine is sourced internationally and supplied to the treating hospital.

What is the availability of Trodelvy® in Mumbai?

Patients in Mumbai can access Trodelvy® via special access programs that allow import of approved international medicines. The treatment is delivered to the hospital where the patient is undergoing care.

I want to buy Trodelvy® in Mumbai—how can I access it?

If you are looking to buy Trodelvy® in Mumbai, the first step is consultation with your oncologist. Once prescribed, the medicine can be arranged from global sources under a compliant import process and delivered to your treating hospital.

I want to buy Trodelvy® in Bangalore—what is the process?

Patients in Bangalore can access Trodelvy® through a regulated pathway that enables the import of medicines for individual use. After prescription approval, the drug is procured internationally and supplied directly to the hospital for treatment.

Can I buy Trodelvy® at major hospitals like Tata, Apollo, or Fortis?

Trodelvy® can be accessed at leading hospitals such as Tata Memorial Centre, Apollo Hospitals, Fortis Healthcare, Max Healthcare, Manipal Hospitals, and Kokilaben Dhirubhai Ambani Hospital through the Named Patient Program (NPP) with a valid oncologist’s prescription. Indian Pharma Network assists with import and delivery to the treating hospital.

How does Trodelvy Import in India work?

Trodelvy Import in India is possible through the Named Patient Program. This means the medicine can be imported for a specific patient with a valid doctor’s prescription. Indian Pharma Network helps manage the complete process, including approvals and delivery, making sure the medicine reaches the patient safely and legally.

Who is a reliable Trodelvy supplier in India?

Indian Pharma Network is a trusted Trodelvy supplier in India, facilitating compliant access through global sourcing channels and structured documentation support for eligible patients under applicable regulatory provisions.

How much does Trodelvy® Injection cost in India?

Trodelvy® is not yet approved in India. However, patients in India can legally access it through the provision called the Named Patient Program (NPP). Trodelvy prices may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Trodelvy cost in India, please call/WhatsApp +91 98104 69557 or send an email to info@indianpharmanetwork.in.

Can Trodelvy® Injections be available in SAARC countries?

Apart from Gulf countries, Trodelvy® Injections can be accessed through import provisions like the Named Patient Program (NPP) in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Trodelvy® Injections in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Trodelvy® Injections online in India?

Yes, one can buy Trodelvy in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not yet registered or available in their country. We can help facilitate the supply of Trodelvy® Injections through legal channels.

Who is an authorized Trodelvy importer in India?

Indian Pharma Network acts as Trodelvy importer in India, assisting with Named Patient Import processes, regulatory documentation, and compliant international procurement for patients requiring this therapy.

In which countries is Trodelvy approved?

Trodelvy® has received regulatory approval across several major global markets, including the United States, Canada, the European Union, China, Japan, Singapore, and South Korea. In addition, regulatory evaluations are ongoing in regions such as Taiwan and Hong Kong.

Can I buy Trodelvy® from Europe, the USA, or other countries?

Trodelvy® is approved and available in regions like Europe, the United States, Canada, Japan, Singapore, and China, but patients in India cannot directly purchase it from abroad. It can be legally accessed through the Named Patient Program (NPP) with a valid prescription. Indian Pharma Network assists with compliant sourcing and delivery to the treating hospital.

What are the storage conditions of Trodelvy® Injections?

Store vials in a refrigerator at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light until time of reconstitution. Do not freeze.